Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

164 Press Releases
DateTitleCompany
09 Dec 15 Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers Pfizer,
Published by
Business Wire
02 Dec 15 Pfizer Receives European Approval to Expand Use of Lung Cancer Treatment XALKORI® (crizotinib) Pfizer
04 Nov 15 Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer Pfizer,
Published by
Business Wire
29 Oct 15 Pfizer Announcement Regarding Allergan plc Pfizer,
Published by
Business Wire
07 Oct 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
07 Oct 15 Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
30 Sep 15 Is 50 Really the New 30? Your Immune System May Not Think So Pfizer,
Published by
Business Wire
25 Sep 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
24 Sep 15 Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab Pfizer,
Published by
Business Wire
24 Sep 15 Merck KGaA, Darmstadt, Germany, and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab Pfizer,
Published by
Business Wire
22 Sep 15 New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin Pfizer,
Published by
Business Wire
22 Jul 15 Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility Pfizer,
Published by
Business Wire
08 Jul 15 Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research Pfizer,
Published by
PharmiWeb.com
25 Jun 15 Pfizer Declares 28-Cent Third-Quarter 2015 Dividend Pfizer,
Published by
PharmiWeb.com
25 Jun 15 Joseph J. Echevarria Elected To Pfizer’s Board Of Directors Pfizer,
Published by
PharmiWeb.com
24 Jun 15 CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age Pfizer,
Published by
PharmiWeb.com
23 Jun 15 New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support Pfizer,
Published by
PharmiWeb.com
23 Jun 15 Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts Pfizer,
Published by
PharmiWeb.com
27 May 14 Pfizer ends attempt to buy AstraZeneca Pfizer,
Published by
theguardian.com
04 Dec 14 Ultibro® Breezhaler®? (indacaterol/glycopyrronium bromide) launched in the UK for the treatment of chronic obstructive pulmonary disease (COPD) Pfizer,
Published by
PharmiWeb.com
17 Nov 14 New Study Shows Taking Vitamin D with a Meal Containing Fat Aids Absorption Pfizer,
Published by
Business Wire
21 Apr 15 Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia Pfizer,
Published by
Business Wire
24 Mar 15 Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts Pfizer,
Published by
PharmiWeb.com
23 Jun 15 Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease Pfizer,
Published by
PharmiWeb.com
14 May 15 Merck and Pfizer to Present Data at ASCO for Avelumab an Investigational Anti-PD-L1 Antibody Pfizer,
Published by
Business Wire
10 Jun 15 Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015) Pfizer,
Published by
PharmiWeb.com
30 Jan 15 NEXIUM CONTROL® NOW AVAILABLE WITHOUT A PRESCRIPTION Pfizer
05 Feb 15 Pfizer Invites Investors Analysts And Media To Join Conference Calls Discussing Pfizer’s Proposed Acquisition of Hospira Pfizer,
Published by
Business Wire
22 Jun 15 Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline Pfizer,
Published by
PharmiWeb.com
14 May 14 Call for 10-year Pfizer pledge as CEO faces new grilling Pfizer,
Published by
Reuters
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.